Symbol="LRMR"
AssetType="Common Stock"
Name="Larimar Therapeutics Inc"
Description="Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. The company is headquartered in Bala Cynwyd, Pennsylvania."
CIK="1374690"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3 CENTER PLAZA, SUITE 610, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="139327000"
EBITDA="-34962000"
PERatio="None"
PEGRatio="None"
BookValue="2.455"
DividendPerShare="0"
DividendYield="0"
EPS="-1.05"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.232"
ReturnOnEquityTTM="-0.403"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.05"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="11.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.634"
EVToRevenue="-"
EVToEBITDA="-2.144"
Beta="0.104"
num_52WeekHigh="6.85"
num_52WeekLow="1.53"
num_50DayMovingAverage="3.689"
num_200DayMovingAverage="4.168"
SharesOutstanding="43269200"
DividendDate="2020-05-29"
ExDividendDate="None"
symbol="LRMR"
open="3.21"
high="3.29"
low="3.17"
price="3.23"
volume="68149.00"
latest_trading_day="2023-07-18"
previous_close="3.22"
change="0.01"
change_percent="0.3106%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="60"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="40"
Volume_recent_avg="266561"
Change_recent_avg="-0.04"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-0.82"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_60"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="40"
Aroon_momentum_negative="60"
image_negative_thumbnail_id_1="1154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0188.jpeg"
image_negative_thumbnail_id_2="119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0057.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="659"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0049.jpeg"
image_positive_thumbnail_id_2="688"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
